AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Saturn V Capital Management LP's Holding History (CIK: 0001964437)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 4,496,487 Value ($000) $54,318 Avg Close $13.58 Range $11.69 - $16.96

Q3 2025

Shares 4,604,878 Value ($000) $62,580 Avg Close $9.41 Range $5.97 - $15.14

Q2 2025

Shares 3,260,570 Value ($000) $20,900 Avg Close $4.86 Range $3.11 - $6.70

Q1 2025

Shares 2,426,436 Value ($000) $8,590 Avg Close $3.56 Range $2.60 - $4.18

Q4 2024

Shares 889,073 Value ($000) $3,361 Avg Close $4.71 Range $2.91 - $7.27

Q4 2023

Shares 1,099,268 Value ($000) $16,181 Avg Close $15.33 Range $11.82 - $18.88

Q3 2023

Shares 886,143 Value ($000) $16,225 Avg Close $21.15 Range $17.80 - $25.48

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	4,496,487	$54,318	$13.58	$11.69 - $16.96
Q3 2025	4,604,878	$62,580	$9.41	$5.97 - $15.14
Q2 2025	3,260,570	$20,900	$4.86	$3.11 - $6.70
Q1 2025	2,426,436	$8,590	$3.56	$2.60 - $4.18
Q4 2024	889,073	$3,361	$4.71	$2.91 - $7.27
Q4 2023	1,099,268	$16,181	$15.33	$11.82 - $18.88
Q3 2023	886,143	$16,225	$21.15	$17.80 - $25.48